|
|
Reference
|
|
|
*** (2012) What is pulmonary hypertension?. American Heart Association, Jun, http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/AboutHighBlood-Pressure/What-is-Pulmonary-Hypertension_UCM_301792_Article.jsp
|
|
[ CR ] [ EČ ][ GS ]
|
Abe, K., Shimokawa, H., Morikawa, K., Uwatoku, T., Oi, K., Matsumoto, Y., Hattori, T., Nakashima, Y., Kaibuchi, K., Sueishi, K., Takeshit, A. (2004) Long-Term Treatment With a Rho-Kinase Inhibitor Improves Monocrotaline-Induced Fatal Pulmonary Hypertension in Rats. Circulation Research, 94(3): 385-393
|
|
[ EČ ][ GS ]
|
Badesch, D.B., Raskob, G.E., Elliott, C.G., i dr. (2010) Pulmonary hypertension: Baseline characteristics from the REVEAL Registry. Chest, 137, 376-387
|
|
[ CR ] [ EČ ][ GS ]
|
Chin, K.M., Rubin, L.J. (2008) Pulmonary Arterial Hypertension. Journal of the American College of Cardiology, 51(16): 1527-1538
|
|
[ EČ ][ 1 ][ GS ]
|
Galiè, N., Hoeper, M.M., Humbert, M., Torbicki, A., Vachiery, J.L., Barberaet, J.A., i dr. (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS),. Eur Heart J., 30(20), str. 2493-537
|
|
[ EČ ][ 1 ][ GS ]
|
Galiè, N., Manes, A., Negro, L., Palazzini, M., Bacchi-Reggiani, M.L., Branzi, A. (2009) A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J., 30(4), str. 394-403
|
|
[ CR ] [ EČ ][ GS ]
|
Guignabert, C., Izikki, M., Tu, L.I., Li, Z., Zadigue, P., Barlier-Mur, A., Hanoun, N., Rodman, D., Hamon, M., Adnot, S., Eddahibi, S. (2006) Transgenic Mice Overexpressing the 5-Hydroxytryptamine Transporter Gene in Smooth Muscle Develop Pulmonary Hypertension. Circulation Research, 98(10): 1323-1330
|
|
[ CR ] [ EČ ][ GS ]
|
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J., Chabot, F., Dromer, C., Pison, C., Reynaud-Gaubert, M., Haloun, A. (2006) Pulmonary Arterial Hypertension in France. American Journal of Respiratory and Critical Care Medicine, 173(9): 1023-1030
|
|
[ CR ] [ EČ ][ GS ]
|
Lapa, M., Dias, B., Jardim, C., Fernandes, C.J.C., Dourado, P.M.M., Figueiredo, M., Farias, A., Tsutsui, J., Terra-Filho, M., Humbert, M., Souza, R. (2009) Cardiopulmonary Manifestations of Hepatosplenic Schistosomiasis. Circulation, 119(11): 1518-1523
|
|
[ CR ] [ PM ] [ EČ ][ 1 ][ GS ]
|
McLaughlin, V.V., Shillington, A. (2002) Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy. Circulation, 106(12): 1477-1482
|
|
[ CR ] [ EČ ][ GS ]
|
McLaughlin, V.V., Archer, S.L., Badesch, D.B., Barst, R.J., Farber, H.W., Lindner, J.R., Mathier, M.A., McGoon, M.D., Park, M.H., Rosenson, R.S., Rubin, L.J., Tapson, V.F., Varga, J. (2009) ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension. Circulation, 119(16): 2250-2294
|
|
[ CR ] [ EČ ][ GS ]
|
Mukerjee, D. (2003) Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Annals of the Rheumatic Diseases, 62(11): 1088-1093
|
|
|
Oudiz, R. (2007) Pulmonary hypertension. Primary, eMedicine, August, Available at URL: http://emedicine.medscape.com/article/301450-overview
|
|
[ CR ] [ EČ ][ GS ]
|
Peacock, A. (2003) Treatment of pulmonary hypertension. BMJ, 326(7394): 835-836
|
|
[ CR ] [ EČ ][ GS ]
|
Petkov, V., Mosgoeller, W., Ziesche, R., Raderer, M., Stiebellehner, L., Vonbank, K., Funk, G., Hamilton, G., Novotny, C., Burian, B., Block, L. (2003) Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. Journal of Clinical Investigation, 111(9): 1339-1346
|
|
[ GS ]
|
Porhownik, N.R., Bshouty, Z. (2007) Pulmonary arterial hypertension: A serious problem. Perspect Cardiol, 23: 33-40
|
|
[ PM ] [ EČ ][ 1 ][ GS ]
|
Rich, S., Dantzker, D.R., Ayres, S.M., Bergofsky, E.H., Brundage, B.H., Detre, K.M., Fishman, A.P., Goldring, R.M., Groves, B.M., Koerner, S.K. (1987) Primary pulmonary hypertension. A national prospective study. Ann Intern Med, 107(2): 216-23
|
|
[ CR ] [ EČ ][ GS ]
|
Rich, S., Kaufmann, E., Levy, P.S. (1992) The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension. New England Journal of Medicine, 327(2): 76-81
|
|
[ EČ ][ 1 ][ GS ]
|
Rubin, L.J., Badesch, D.B. (2005) Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med, 143, str. 282-92
|
|
[ EČ ][ 1 ][ GS ]
|
Rudarakanchana, N., Trembath, R.C., Morrell, N.W. (2001) New insights into the pathogenesis and treatment of primary pulmonary hypertension. Thorax, 56, str. 888-90
|
|
[ CR ] [ EČ ][ 1 ][ GS ]
|
Runo, J.R., Loyd, J.E. (2003) Primary pulmonary hypertension. Lancet, 361(9368): 1533-1544
|
|
[ CR ] [ EČ ][ GS ]
|
Schermuly, R.T. (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. Journal of Clinical Investigation, 115(10): 2811-2821
|
|
[ PM ] [ EČ ][ 1 ][ GS ]
|
Simonneau, G., Robbins, I.M., Beghetti, M., Channick, R.N., Delcroix, M., Denton, C.P., Elliott, C., Gaine, S.P., Gladwin, M.T., Jing, Z., Krowka, M.J., Langleben, D., Nakanishi, N., Souza, R. (2009) Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology, 54(1 Suppl): S43-54
|
|
[ CR ] [ EČ ][ GS ]
|
Sitbon, O., Humbert, M., Jäis, X. (2005) Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension. ACC Current Journal Review, 14(10): 30
|
|
[ CR ] [ EČ ][ GS ]
|
Thenappan, T., Shah, S.J., Rich, S., Gomberg-Maitland, M. (2007) A USA-based registry for pulmonary arterial hypertension: 1982 2006. European Respiratory Journal, 30(6): 1103-1110
|
|
[ EČ ][ GS ]
|
Yigla, M., Kramer, M.R., Bendayan, D., i dr. (2004) Unexplained severe pulmonary hypertension in the elderly: report on 14 patients. Isr Med Assoc J, 6: 78-81
|
|
|
|
|